BR0208992A - Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila - Google Patents
Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arilaInfo
- Publication number
- BR0208992A BR0208992A BR0208992-0A BR0208992A BR0208992A BR 0208992 A BR0208992 A BR 0208992A BR 0208992 A BR0208992 A BR 0208992A BR 0208992 A BR0208992 A BR 0208992A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- compounds
- azapolytic
- aryl fused
- substituted indenes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
"PROCESSO PARA A PREPARAçãO DE INDENOS 1,3-SUBSTITUìDOS E COMPOSTOS AZAPOLICìCLICOS FUNDIDOS COM ARILA". A presente invenção refere-se a processos para a preparação de qualquer um dos intermediários indenos 1,3-substituídos de fórmulas (Ia), (Ib) e (Ic) ou uma sua mistura: em que R^ 1^, R^ 2^ , R^ 3^, R^ 4^ e R^ 5~ são como aqui definidos adiante. Os compostos de fórmulas (Ia), (Ib) e (Ic) ou suas misturas são úteis na preparação de compostos de fórmula (II): em que R^ 2^, R^ 3^ e R^ 6^ também são aqui definidos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28513101P | 2001-04-20 | 2001-04-20 | |
PCT/IB2002/000660 WO2002085843A2 (en) | 2001-04-20 | 2002-03-04 | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208992A true BR0208992A (pt) | 2004-04-27 |
Family
ID=23092860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208992-0A BR0208992A (pt) | 2001-04-20 | 2002-03-04 | Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila |
Country Status (25)
Country | Link |
---|---|
US (2) | US7091372B2 (pt) |
EP (1) | EP1383733B1 (pt) |
JP (1) | JP2004527545A (pt) |
KR (1) | KR100551183B1 (pt) |
CN (1) | CN1321107C (pt) |
AR (2) | AR035957A1 (pt) |
AT (1) | ATE388135T1 (pt) |
AU (1) | AU2002234836B2 (pt) |
BR (1) | BR0208992A (pt) |
CA (1) | CA2443946A1 (pt) |
CZ (1) | CZ20032814A3 (pt) |
DE (1) | DE60225433T2 (pt) |
DK (1) | DK1383733T3 (pt) |
ES (1) | ES2300430T3 (pt) |
HK (1) | HK1062170A1 (pt) |
HU (1) | HUP0303811A3 (pt) |
IL (1) | IL157881A0 (pt) |
MX (1) | MXPA03009527A (pt) |
PL (1) | PL366657A1 (pt) |
PT (1) | PT1383733E (pt) |
RU (1) | RU2282619C9 (pt) |
TW (1) | TWI244472B (pt) |
WO (1) | WO2002085843A2 (pt) |
YU (1) | YU78303A (pt) |
ZA (1) | ZA200307205B (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE447772T1 (de) * | 2001-11-16 | 2009-11-15 | Cdt Oxford Ltd | Leuchtdiode und verwendete verbindungen |
CA2511762A1 (en) * | 2002-11-25 | 2004-06-10 | Pfizer Products Inc. | Improved process for the preparation of 1,3-substituted indenes |
MXPA05007565A (es) * | 2003-01-15 | 2005-09-21 | Pfizer Prod Inc | Procedimiento mejorado de preparacion de lactamas policiclicas fusionadas con arilos. |
ES2310730T3 (es) * | 2003-06-04 | 2009-01-16 | Pfizer Products Inc. | Preparacion de quinoxalinas sustituidas a partir de la dianilina con 2,3-dihidroxi-1,4-dioxano. |
EP1648872A2 (en) * | 2003-07-21 | 2006-04-26 | Pfizer Products Inc. | Aryl fused azapolycyclic compounds |
DE602006013688D1 (de) * | 2005-11-16 | 2010-05-27 | Hoffmann La Roche | Neues verfahren zur herstellung von thoc |
DE102006024903A1 (de) * | 2006-05-24 | 2007-11-29 | Basf Ag | Verfahren zur Vermeidung von Fumarsäureablagerungen bei der Herstellung von Maleinsäureanhydrid |
ES2374337T3 (es) | 2007-05-16 | 2012-02-15 | Nycomed Gmbh | Derivados de pirazolona como inhibidores de pde4. |
EP2019107A1 (en) | 2007-07-26 | 2009-01-28 | Dynamit Nobel GmbH Explosivstoff- und Systemtechnik | Use of phosphonium salts in coupling reactions and process for their manufacture |
WO2009065872A2 (en) * | 2007-11-20 | 2009-05-28 | Medichem, S.A. | Improved processes for the synthesis of varenicline l-tartrate |
EP2260037A2 (en) * | 2008-02-15 | 2010-12-15 | Medichem, S.A. | A polymorphic form of a pyrazino [2,3-h] [3] benzazepine derivative |
CA2709774C (en) | 2008-05-22 | 2012-10-02 | Teva Pharmaceutical Industries Ltd. | Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate |
WO2009155403A2 (en) * | 2008-06-19 | 2009-12-23 | Teva Pharmaceutical Industries Ltd. | Processes for the preparation of varenicline and intermediates thereof |
US20100010221A1 (en) * | 2008-07-10 | 2010-01-14 | Revital Lifshitz-Liron | Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt |
RU2012102052A (ru) | 2009-06-22 | 2013-11-20 | Тева Фармасьютикал Индастриз Лтд. | Твердые формы солей варениклина и способы их получения |
US20120004239A1 (en) | 2010-06-11 | 2012-01-05 | Medichem, S.A. | Process for Preparing Quinoxaline Derivatives |
KR101603427B1 (ko) * | 2014-08-14 | 2016-03-15 | 영남대학교 산학협력단 | 케스케이드 반응을 통한 인덴 유도체의 효율적 합성방법 |
CN104478803A (zh) * | 2014-12-19 | 2015-04-01 | 连云港恒运医药科技有限公司 | 伐尼克兰中间体及其硝基还原杂质的制备方法 |
KR20180041154A (ko) * | 2015-08-14 | 2018-04-23 | 보울로스 & 쿠퍼 파마슈티컬스 피티와이 리미티드 | 아릴 화합물의 합성 |
CA3030147A1 (en) | 2016-07-07 | 2018-01-11 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
US10961296B2 (en) * | 2017-11-10 | 2021-03-30 | Howard Hughes Medical Institute | Modified ligand-gated ion channels and methods of use |
CN111995519B (zh) * | 2020-09-26 | 2022-08-26 | 安徽金禾实业股份有限公司 | 一种3-甲氧基丙烯酸甲酯的制备方法 |
CN115322105A (zh) * | 2021-05-11 | 2022-11-11 | 江苏润安制药有限公司 | 一种合成艾拉莫德关键中间体的方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5479598A (en) * | 1992-10-23 | 1995-12-26 | International Business Machines Corporation | Compact graphical parallel program user output interface controlled directly by the parallel computer program |
DE69409445D1 (de) * | 1993-07-27 | 1998-05-14 | Ibm | Prozessüberwachung in einem Mehrfachverarbeitungsanbieter |
US6289368B1 (en) * | 1995-12-27 | 2001-09-11 | First Data Corporation | Method and apparatus for indicating the status of one or more computer processes |
US5928323A (en) * | 1996-05-30 | 1999-07-27 | Sun Microsystems, Inc. | Apparatus and method for dynamically generating information with server-side software objects |
FR2751448B1 (fr) * | 1996-07-17 | 1999-01-15 | Bull Sa | Procede de surveillance en temps reel d'un systeme informatique pour son administration et l'aide a sa maintenance en phase d'exploitation |
US6112194A (en) * | 1997-07-21 | 2000-08-29 | International Business Machines Corporation | Method, apparatus and computer program product for data mining having user feedback mechanism for monitoring performance of mining tasks |
US6119165A (en) * | 1997-11-17 | 2000-09-12 | Trend Micro, Inc. | Controlled distribution of application programs in a computer network |
US6100887A (en) * | 1997-12-05 | 2000-08-08 | At&T Corporation | Reusable reversible progress indicator software component for a graphical user interface |
ATE386024T1 (de) * | 1997-12-31 | 2008-03-15 | Pfizer Prod Inc | Arylkondensierte azapolycyclische derivate |
US6605610B1 (en) * | 1997-12-31 | 2003-08-12 | Pfizer Inc | Aryl fused azapolycyclic compounds |
US6151357A (en) * | 1998-01-16 | 2000-11-21 | Aspect Communications Corporation | Method and apparatus for displaying a visual indication of a transmission status |
US6108003A (en) * | 1998-03-18 | 2000-08-22 | International Business Machines Corporation | Maintaining visibility and status indication of docked applications and application bars |
ES2213354T3 (es) * | 1998-04-29 | 2004-08-16 | Pfizer Products Inc. | Compuestos azapoliciclicos condensados con arilo. |
FR2788982B1 (fr) * | 1999-02-02 | 2002-08-02 | Synthelabo | Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique |
WO2001002340A2 (en) * | 1999-07-02 | 2001-01-11 | Igt Pharma Inc. | Novel aminoindanes |
IL137937A0 (en) * | 1999-08-27 | 2001-10-31 | Pfizer Prod Inc | A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
US20010036943A1 (en) * | 2000-04-07 | 2001-11-01 | Coe Jotham W. | Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines |
US20010036949A1 (en) * | 2000-05-09 | 2001-11-01 | Coe Jotham Wadsworth | Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal |
US20020010192A1 (en) * | 2000-06-02 | 2002-01-24 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss |
US20020016334A1 (en) * | 2000-07-31 | 2002-02-07 | Coe Jotham Wadsworth | Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
-
2002
- 2002-03-04 CA CA002443946A patent/CA2443946A1/en not_active Abandoned
- 2002-03-04 AU AU2002234836A patent/AU2002234836B2/en not_active Ceased
- 2002-03-04 MX MXPA03009527A patent/MXPA03009527A/es active IP Right Grant
- 2002-03-04 AT AT02701498T patent/ATE388135T1/de not_active IP Right Cessation
- 2002-03-04 PL PL02366657A patent/PL366657A1/xx not_active Application Discontinuation
- 2002-03-04 WO PCT/IB2002/000660 patent/WO2002085843A2/en active IP Right Grant
- 2002-03-04 JP JP2002583371A patent/JP2004527545A/ja active Pending
- 2002-03-04 EP EP02701498A patent/EP1383733B1/en not_active Expired - Lifetime
- 2002-03-04 DE DE60225433T patent/DE60225433T2/de not_active Expired - Fee Related
- 2002-03-04 PT PT02701498T patent/PT1383733E/pt unknown
- 2002-03-04 CN CNB028085124A patent/CN1321107C/zh not_active Expired - Fee Related
- 2002-03-04 RU RU2003130751/04A patent/RU2282619C9/ru not_active IP Right Cessation
- 2002-03-04 CZ CZ20032814A patent/CZ20032814A3/cs unknown
- 2002-03-04 KR KR1020037013659A patent/KR100551183B1/ko not_active IP Right Cessation
- 2002-03-04 YU YU78303A patent/YU78303A/sh unknown
- 2002-03-04 DK DK02701498T patent/DK1383733T3/da active
- 2002-03-04 HU HU0303811A patent/HUP0303811A3/hu unknown
- 2002-03-04 BR BR0208992-0A patent/BR0208992A/pt not_active IP Right Cessation
- 2002-03-04 IL IL15788102A patent/IL157881A0/xx unknown
- 2002-03-04 ES ES02701498T patent/ES2300430T3/es not_active Expired - Lifetime
- 2002-04-15 TW TW091107632A patent/TWI244472B/zh not_active IP Right Cessation
- 2002-04-17 US US10/124,135 patent/US7091372B2/en not_active Expired - Fee Related
- 2002-04-18 AR ARP020101424A patent/AR035957A1/es active IP Right Grant
-
2003
- 2003-09-15 ZA ZA200307205A patent/ZA200307205B/en unknown
-
2004
- 2004-03-17 AR ARP040100885A patent/AR043636A2/es active IP Right Grant
- 2004-07-14 HK HK04105132A patent/HK1062170A1/xx not_active IP Right Cessation
-
2005
- 2005-11-23 US US11/286,055 patent/US7186870B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0208992A (pt) | Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila | |
BR0212185A (pt) | Compostos e métodos para a preparação de compostos | |
BR0108871A (pt) | Composto, processo de preparação de compostos, e, composição farmacêutica | |
BR0210747A (pt) | Compostos amina e composições curáveis derivadas dos mesmos | |
BR0115580A (pt) | Derivados de 3-aroilindol e a utilizaçao dos mesmos como agonistas dos receptores cb2 | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
BR0215493A (pt) | Processo para preparação de ésteres escopìnicos | |
BR9911783A (pt) | Compostos cìclicos substituìdos, processo para sua preparação e composições farmacêuticas que os contêm | |
BR0213380A (pt) | Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes | |
BR9905636A (pt) | Processos para preparar um metaloaluminossilicato e para preparar uma composição de aluminossilicato, e, composição de metaloaluminossilicato | |
BRPI0406596A (pt) | Métodos para tratar a dor articular e melhorar o sono utilizando um agonista/antagonista de estrogênio | |
BRPI0418047A (pt) | processo para a preparação de derivados de piridina | |
BR0301667A (pt) | Processo para a preparação de polìmeros em emulsão com pureza elevada | |
BR0314312A (pt) | Processo para preparar um composto, e, composto | |
BR0213481A (pt) | Sondas | |
BRPI0412910A (pt) | derivados de nicotinamida úteis como inibidores de pde4 | |
BR9807988A (pt) | Processo para a preparação de um composto, e, composto. | |
BR0101228A (pt) | Ormoceres, processo para a sua preparação, assimcomo aplicação | |
BR0214582A (pt) | Derivados de piperazina para uso como antagonista do receptor ccr-3 no tratamento de asma | |
BR0316702A (pt) | xprocesso para preparação de (s)-pantoprazol | |
BR0309568A (pt) | Triazolopirimidinas | |
BR0211903A (pt) | Isoxazolopiridinonas | |
BR9912138A (pt) | Compostos cìclicos úteis no tratamento de dislipidemia, aterosclerose e diabetes, composções farmacêuticas e processo para preparação | |
BR9705456A (pt) | Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |